|
[1]
|
Crosbie, E.J., Kitson, S.J., McAlpine, J.N., Mukhopadhyay, A., Powell, M.E. and Singh, N. (2022) Endometrial Cancer. The Lancet, 399, 1412-1428. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Bujnak, A., File, B. and Tewari, K. (2025) Clinical Use of Dostarlimab in Advanced Stage and Recurrent Endometrial Cancer: Patient Selection and Perspectives. Cancer Management and Research, 17, 161-170. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Chandramohan, A., Manchanda, S., Renganathan, R., Popat, P.B., Shah, D., Dhamija, E., et al. (2023) Impact of the 2023 FIGO Staging System for Endometrial Cancer on the Use of Imaging Services: An Indian Perspective. Indian Journal of Radiology and Imaging, 34, 309-323. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Sun, J., Zhao, J., Jiang, F., Wang, L., Xiao, Q., Han, F., et al. (2023) Identification of Novel Protein Biomarkers and Drug Targets for Colorectal Cancer by Integrating Human Plasma Proteome with Genome. Genome Medicine, 15, Article No. 75. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Su, W., Gu, X., Dou, M., Duan, Q., Jiang, Z., Yin, K., et al. (2023) Systematic Druggable Genome-Wide Mendelian Randomisation Identifies Therapeutic Targets for Alzheimer’s Disease. Journal of Neurology, Neurosurgery & Psychiatry, 94, 954-961. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Birney, E. (2021) Mendelian Randomization. Cold Spring Harbor Perspectives in Medicine, 12, a041302. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Masuda, T., Ogawa, K., Kamatani, Y., Murakami, Y., Kimura, T. and Okada, Y. (2020) A Mendelian Randomization Study Identified Obesity as a Causal Risk Factor of Uterine Endometrial Cancer in Japanese. Cancer Science, 111, 4646-4651. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Painter, J.N., O’Mara, T.A., Marquart, L., Webb, P.M., Attia, J., Medland, S.E., et al. (2016) Genetic Risk Score Mendelian Randomization Shows That Obesity Measured as Body Mass Index, but Not Waist: Hip Ratio, Is Causal for Endometrial Cancer. Cancer Epidemiology, Biomarkers & Prevention, 25, 1503-1510. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Freuer, D., Linseisen, J., O’Mara, T.A., Leitzmann, M., Baurecht, H., Baumeister, S., et al. (2021) Body Fat Distribution and Risk of Breast, Endometrial, and Ovarian Cancer: A Two-Sample Mendelian Randomization Study. Cancers, 13, Article No. 5053. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kennedy, O.J., Bafligil, C., O’Mara, T.A., Wang, X., Evans, D.G., Kar, S., et al. (2022) Child and Adult Adiposity and Subtype-Specific Endometrial Cancer Risk: A Multivariable Mendelian Randomisation Study. International Journal of Obesity, 47, 87-90. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Ling, S., Brown, K., Miksza, J.K., Howells, L., Morrison, A., Issa, E., et al. (2020) Association of Type 2 Diabetes with Cancer: A Meta-Analysis with Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People. Diabetes Care, 43, 2313-2322. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Pearson-Stuttard, J., Papadimitriou, N., Markozannes, G., Cividini, S., Kakourou, A., Gill, D., et al. (2021) Type 2 Diabetes and Cancer: An Umbrella Review of Observational and Mendelian Randomization Studies. Cancer Epidemiology, Biomarkers & Prevention, 30, 1218-1228. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Yuan, S., Kar, S., Carter, P., Vithayathil, M., Mason, A.M., Burgess, S., et al. (2020) Is Type 2 Diabetes Causally Associated with Cancer Risk? Evidence from a Two-Sample Mendelian Randomization Study. Diabetes, 69, 1588-1596. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Zhang, X., Pu, C., Wang, L., Lin, X., Lai, H., Wu, S., et al. (2024) Unraveling the Causal Association between Lifestyle and Metabolic Factors with Endometrial Cancer: Evidence from a Mendelian Randomization Study. Discover Oncology, 15, Article No. 575. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Thompson, D.J., O’Mara, T.A., Glubb, D.M., Painter, J.N., Cheng, T., Folkerd, E., et al. (2015) CYP19A1 Fine-Mapping and Mendelian Randomization: Estradiol Is Causal for Endometrial Cancer. Endocrine-Related Cancer, 23, 77-91. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Larsson, S.C., Kar, S., Perry, J.R.B., Carter, P., Vithayathil, M., Mason, A.M., et al. (2021) Serum Estradiol and 20 Site-Specific Cancers in Women: Mendelian Randomization Study. The Journal of Clinical Endocrinology & Metabolism, 107, e467-e474. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Johansson, Å., Schmitz, D., Höglund, J., Hadizadeh, F., Karlsson, T. and Ek, W.E. (2022) Investigating the Effect of Estradiol Levels on the Risk of Breast, Endometrial, and Ovarian Cancer. Journal of the Endocrine Society, 6, bvac100. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Ruth, K.S., Day, F.R., Tyrrell, J., Thompson, D.J., Wood, A.R., Mahajan, A., et al. (2020) Using Human Genetics to Understand the Disease Impacts of Testosterone in Men and Women. Nature Medicine, 26, 252-258. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Mullee, A., Dimou, N., Allen, N., O’Mara, T., Gunter, M.J. and Murphy, N. (2021) Testosterone, Sex Hormone-Binding Globulin, Insulin-Like Growth Factor-1 and Endometrial Cancer Risk: Observational and Mendelian Randomization Analyses. British Journal of Cancer, 125, 1308-1317. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Kolben, T., Mannewitz, M., Perleberg, C., Schnell, K., Anz, D., Hahn, L., et al. (2022) Presence of Regulatory T-Cells in Endometrial Cancer Predicts Poorer Overall Survival and Promotes Progression of Tumor Cells. Cellular Oncology, 45, 1171-1185. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Mandal, G., Biswas, S., Anadon, C.M., Yu, X., Gatenbee, C.D., Prabhakaran, S., et al. (2022) Iga-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial Cancer. Cancer Research, 82, 859-871. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Li, Y., Liu, J., Wang, Q., Zhou, Y., Zhang, C. and Pei, J. (2024) The Causal Effects of Genetically Determined Immune Cells on Gynecologic Malignancies: A Mendelian Randomization Study. Frontiers in Oncology, 14, Article ID: 1371309. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Zou, X., Shen, J., Zhang, H., Kong, F., Jin, X. and Zhang, L. (2024) Association between Immune Cells and Endometrial Cancer: A Bidirectional Mendelian Randomization Study. Medicine, 103, e38129. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Zheng, W., Lin, X., Chen, H., Yang, Z., Zhao, H., Li, S., et al. (2025) Gut Microbiota and Endometrial Cancer: Research Progress on the Pathogenesis and Application. Annals of Medicine, 57, Article ID: 2451766. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Kong, Y., Liu, S., Wang, X. and Qie, R. (2024) Associations between Gut Microbiota and Gynecological Cancers: A Bi-Directional Two-Sample Mendelian Randomization Study. Medicine, 103, e37628. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Zhu, J., Zhang, T., Jiang, J., Yang, M., Xia, N. and Chen, Y. (2024) Genetic Variation Perspective Reveals Potential Drug Targets for Subtypes of Endometrial Cancer. Scientific Reports, 14, Article No. 28180. [Google Scholar] [CrossRef] [PubMed]
|